PMDA Review Period Reduced for Both Priority, Standard Products

December 28, 2012
At a meeting of its Review and Safety Committee on December 26, the Pharmaceuticals and Medical Devices Agency (PMDA) reported the latest status of the new drug application (NDA) review and trend of safety measures in the first half of...read more